Your browser doesn't support javascript.
loading
Association between synthetic sealants and increased complication rates in posterior fossa decompression with duraplasty for Chiari malformations regardless of graft type.
Makoshi, Ziyad; Toop, Nathaniel; Smith, Luke G F; Drapeau, Annie; Pindrik, Jonathan; Sribnick, Eric A; Leonard, Jeffrey; Shaikhouni, Ammar.
Afiliación
  • Makoshi Z; 1Department of Pediatric Neurosurgery, Nationwide Children's Hospital, Columbus; and.
  • Toop N; 2Department of Neurosurgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Smith LGF; 2Department of Neurosurgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Drapeau A; 1Department of Pediatric Neurosurgery, Nationwide Children's Hospital, Columbus; and.
  • Pindrik J; 2Department of Neurosurgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Sribnick EA; 1Department of Pediatric Neurosurgery, Nationwide Children's Hospital, Columbus; and.
  • Leonard J; 2Department of Neurosurgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Shaikhouni A; 1Department of Pediatric Neurosurgery, Nationwide Children's Hospital, Columbus; and.
J Neurosurg Pediatr ; : 1-10, 2022 Sep 09.
Article en En | MEDLINE | ID: mdl-36087335
OBJECTIVE: Dural sealants are commonly used in posterior fossa decompression with duraplasty (PFDD) for Chiari malformation type I (CMI). Prior evidence suggests that combining certain sealants with some graft material is associated with an increased rate of complications. In 2018, the authors noted an increased rate of symptomatic pseudomeningocele and aseptic meningitis after PFDD in CMI patients. The authors utilized retrospective and prospective analyses to test the hypothesis that complication rates increase with the use or combination of certain sealants and grafts. METHODS: The analysis was split into 2 periods. The authors retrospectively reviewed patients who underwent PFDD for CMI at their center between August 12, 2011, and December 31, 2018. The authors then eliminated use of DuraSeal on the basis of the retrospective analysis and prospectively examined complication rates from January 1, 2019, to August 4, 2021. The authors defined a complication as symptomatic pseudomeningocele, bacterial or aseptic meningitis, cerebrospinal fluid leak, subdural hygroma, hydrocephalus, surgical site infection, or wound dehiscence. RESULTS: From 2011 to 2018, complications occurred in 24.5% of 110 patients. Sealant choice was correlated with complication rates: no sealant (0%), Tisseel (6%), and DuraSeal (15.3%) (p < 0.001). No difference in complication rate was noted on the basis of choice of graft material (p = 0.844). After eliminating DuraSeal, the authors followed 40 patients who underwent PFDD after 2018. The complication rate decreased to 12.5%. All complications after 2018 were associated with Tisseel. CONCLUSIONS: At the authors' single center, use of sealants in PFDD surgery for CMI, especially DuraSeal, was correlated with a higher complication rate. Eliminating DuraSeal led to a significant decrease in the rate of symptomatic pseudomeningocele and aseptic meningitis.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Neurosurg Pediatr Asunto de la revista: NEUROCIRURGIA / PEDIATRIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Neurosurg Pediatr Asunto de la revista: NEUROCIRURGIA / PEDIATRIA Año: 2022 Tipo del documento: Article